Cardiac resynchronisation may reduce all-cause mortality: Meta-analysis of preliminary COMPANION data with CONTAK-CD, InSync ICD, MIRACLE and MUSTIC

International Journal of Cardiology

Volumn 93, Issue 2-3, 2004, Pages 101-103

  Salukhe, Tushar V ^a,b   Dimopoulos, Konstantinos ^a,b   Francis, Darrel ^a,c  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

Author keywords

All cause mortality; Cardiac resynchronisation; COMPANION data

Indexed keywords

CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; DEFIBRILLATOR; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART PACING; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW;

EID: 1242294600     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2003.10.002     Document Type: Editorial

References (13)

1. Cazeau S., Leclercq C., Lavergne T.et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N. Engl. J. Med. 344:2001;873-880.
2. Abraham W.T., Fisher W.G., Smith A.L.et al. Cardiac resynchronization in chronic heart failure. N. Engl. J. Med. 346:2002;1845-1853.
3. Abraham W.T. Rationale and design of a randomized clinical trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with advanced heart failure: the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). J. Card. Fail. 6:2000;369-380.
4. Summary of Safety and Effectiveness: Medtronic InSync Biventricular Pacing System [report]. Available at: http://www.fda.gov/cdrh/pdf/p010015.html . Accessed on 1 Oct. 2003.
5. Barold H.S. Preliminary clinical review of Medtronic's InSync MIRACLE PMA [report]. May 29, 2001. 2001;. Available at: http://www.fda.gov/cdrh/panel/ briefing/071001-t2-r2.html . Accessed on 1 Oct. 2003.
6. Abraham W.T., Young J.B., Leon A.R. Medtronic InSync ICD Cardiac Resynchronization System [draft sponsor presentation]. US Food and Drug Administration Center for Devices and Radiological Health Circulatory System Devices Advisory Panel meeting. March 5, 2002; Gaithersburg, MD:2002;. Available at: http://www.fda.gov/ohrms/dockets/ac/02/briefing/3843b2.htm . Accessed on 1 Oct. 2003.
7. Barold H.S., Gray G. Clinical and statistical summary: Medtronic InSync ICD Cardiac Resynchronization System [FDA presentation]. US Food and Drug Administration Center for Devices and Radiological Health Circulatory System Devices Advisory Panel meeting. March 5, 2002; Gaithersburg, MD:2003;. Available at: http://www.fda.gov/ohrms/dockets/ac/02/briefing/3843b2.htm . Accessed on 1 Oct. 2003.
8. Summary of Safety and Effectiveness: Medtronic InSync ICD Model 7272 [report]. Updated December 2001. Available at: http://www.fda.gov/ohrms/dockets/ ac/02/briefing/3843b2.htm . Accessed on 1 Oct. 2003.
9. Summary of Safety and Effectiveness: Guidant CONTAK CD CRT-D System [report]. US Food and Drug Administration Web site. Available at: http://www.fda.gov/cdrh/pdf/p010012.html . Accessed on 1 Oct. 2003.
10. Guidant Corp P010012. CONTAK CD and Easy Trak Lead System [transcript]. US Food and Drug Administration Center for Devices and Radiological Health Circulatory System Devices Advisory panel meeting; July 10, 2001; Gaithersburg, Md:11-234. Available at: http://www.fda.gov/ohrms/dockets/ac/cdrh01.htm . Accessed on 1 Oct. 2003.
11. Salukhe T.V., Francis D.P., Sutton R. Comparison of medical therapy, pacing and defibrillation in heart failure (COMPANION) trial terminated early; combined biventricular pacemaker-defibrillators reduce all-cause mortality and hospitalization. Int. J. Cardiol. 87:2003;119-120.
12. Bristow M.R., Saxon L.A., Boehmer J.et al. Cardiac resynchronisation therapy (CRT) reduces hospitalisations and CRT+ an implantable defibrillator (CRT-D) reduces mortality in chronic heart failure: preliminary results of the COMPANION trial. American College of Cardiology late-breaker presentation. vol. 13:2003 (March);American College of Cardiology Congress, Chicago, IL, USA.
13. Bradley D.J., Bradley E.A., Baughman K.L.et al. Cardiac resynchronisation and death from progressive heart failure: a meta-analysis of randomised-controlled trials. JAMA. 289(6):2003 (Feb 12);730-740.